CLChangfan Lin

Changfan Lin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Changfan Lin has a total of 38 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    AAV tools enable functional modulation and readout of central and peripheral nervous systems in spiny mice

    by Jin Hyung Alex Chung, Renée R. Donahue, Jessica A. Griffiths, Yujie Fan, Changfan Lin, Xinhong Chen, Sayan Dutta, Sarkis K. Mazmanian, Ashley W. Seifert, Viviana Gradinaru

    Among mammals, spiny mice ( Acomys spp.) exhibit the unique capacity to regenerate parts of their nervous system. Studying this phenomenon has the potential to reveal new targets that can slow or halt human neurodegenerative disorders. Unfortunately, research tools (e.g., transgenic lines, gene delivery vehicles) are lacking compared to those available for other rodent models. Here, we tested systemic adeno-associated viral vectors (AAVs) in Acomys dimidiatus and identified three promising candidates: X1.1, CAP-Mac, and MaCPNS1. Characterizing their tropism following intravenous delivery, we found that in the brain, MaCPNS1 and X1.1 primarily transduced astrocytes. In the peripheral nervous system, MaCPNS1 efficiently transduced dorsal root ganglia, axon bundles of the ear pinnae, and enteric neurons throughout the gastrointestinal tract. As a proof-of-concept, we used MaCPNS1 to chemogenetically modulate the activity of enteric neurons, successfully decreasing gastric motility in vivo and increasing colonic motility ex vivo. We expect these findings to enable functional studies of the uniquely regenerative nervous system of Acomys , which may in turn help advance neuroregenerative therapeutics for humans. Summary Statement: Identification of an AAV tool to efficiently deliver transgenes to the central and peripheral nervous systems of spiny mice enables functional studies of the nervous system in a mammalian model of regeneration.

  • Open Access

    AAVs Targeting Human Carbonic Anhydrase IV Enhance Gene Delivery to the Brain

    by Changfan Lin, Xinhong Chen, Jonathan D. Hoang, Fiona Ristic, Yujie Fan, Seongmin Jang, Jin Hyung Alex Chung, Erin E. Sullivan, Tomasz Gawda, Bill Kavvathas, et al.

    Summary: Clinically approved gene therapies based on natural adeno-associated virus (AAV) serotypes have restricted applications, particularly in the brain, due to their poor targeting, high dose requirements, and resulting safety concerns. Directed evolution of enhanced AAV capsids in mice or non-human primates (NHPs) has resulted in markedly improved performance in those species, but inter-species differences present a serious challenge for translating these vectors into human therapies. Here, we engineer AAVs to target human carbonic anhydrase IV (CA-IV), a recently identified blood-brain barrier (BBB) transcytosis receptor. Among known transcytosis receptors, CA-IV is notable for its relatively specific expression in brain endothelial cells and the potency of AAVs that target it in mice. CA-IV’s AAV binding site, and thus the mouse vectors’ enhanced brain potency, is not conserved across species, so we employed a two-phase engineering strategy to identify AAVs optimized for human CA-IV-dependent gene delivery to the brain. We first used in vitro receptor-based selection of a vast AAV library to exclude capsids that do not bind human CA-IV, followed by in vivo selection in “humanized” mice expressing human CA-IV in brain endothelial cells. Notably, we find that human CA-IV binding capsid variants that were poorly enriched in the pull-down selection outperform strong binders in vivo. The most promising vector, AAV-hCA4-IV77, engages human CA-IV to achieve 100-fold greater brain transduction than AAV9, with robust neuronal and astrocytic coverage throughout multiple brain regions. These results advance our understanding of receptor-targeted capsid design and support the therapeutic potential of human CA-IV-engaging AAVs.

  • Open Access

    Programmable self-assembling system to model intracellular protein aggregation and decode neurodegenerative diseases

    by Yujie Fan, Jonathan D. Hoang, Chelsie Steele, Yochana Benchetrit, Sayan Dutta, Gerard M. Coughlin, Nathan Appling, Xiaozhe Ding, Changfan Lin, Zhe Qu, et al.

    Pathological protein aggregation is a conserved feature of neurodegenerative diseases. However, slow progression, aggregates heterogeneity and selective vulnerability make it challenging to model diseases and dissect mechanisms. Here, we present a genetically-encoded, modular platform of self-assembling protein that enables inducible, tunable and cell-type-specific formation of intracellular protein aggregates. We engineered self-assembling variants of α-synuclein (SAS), Tau, and TDP-43, recapitulating hallmarks of Parkinson’s disease, Alzheimer’s disease, and ALS, respectively. SAS formed Lewy body-like inclusions, nucleated endogenous α-synuclein, triggered neuroinflammation and neurite degeneration; Self-assembling-Tau induced tangles formation, extracellular Aβ and severe neurodegeneration; Self-assembling-TDP caused TDP-43 mislocalization and cytoplasmic inclusions with mild degeneration. Notably, the system revealed disease-specific aggregate-organelle interactions. In vivo , systemic or dopamine neuron-targeted delivery of SAS induced progressive motor deficits, dopaminergic neuron loss, and microglial activation. Our self-assembling system robustly mirrors histological, transcriptional, and behavioral features of human disease, providing a powerful platform to dissect mechanisms and accelerate therapeutic development. Graphical


  • Open Access

    The cofactor-dependent folding mechanism of Drosophila cryptochrome revealed by single-molecule pulling experiments

    by Sahar Foroutannejad, Lydia L. Good, Changfan Lin, Zachariah I. Carter, Mahlet G. Tadesse, Aaron L. Lucius, Brian R. Crane, Rodrigo A. Maillard

    The link between cofactor binding and protein activity is well-established. However, how cofactor interactions modulate folding of large proteins remains unknown. We use optical tweezers, clustering and global fitting to dissect the folding mechanism of Drosophila cryptochrome (dCRY), a 542-residue protein that binds FAD, one of the most chemically and structurally complex cofactors in nature. We show that the first dCRY parts to fold are independent of FAD, but later steps are FAD-driven as the remaining polypeptide folds around the cofactor. FAD binds to largely unfolded intermediates, yet with association kinetics above the diffusion-limit. Interestingly, not all FAD moieties are required for folding: whereas the isoalloxazine ring linked to ribitol and one phosphate is sufficient to drive complete folding, the adenosine ring with phosphates only leads to partial folding. Lastly, we propose a dCRY folding model where regions that undergo conformational transitions during signal transduction are the last to fold.


  • Open Access

    The cofactor-dependent folding energy landscape of a light-sensing protein revealed by single-molecule pulling experiments

    by Rodrigo Maillard, Sahar Foroutannejad, Lydia Good, Changfan Lin, Zachariah Ingram, Mahlet Tadesse, Aaron Lucius, Brian Crane

    The functional link between cofactor binding and protein activity is well established, but how cofactor interactions with the polypeptide reshape the folding energy landscape of large and multidomain proteins is unknown. Here, we use optical tweezers in combination with a novel analytical framework that integrates clustering, bootstrapping and global fitting of kinetic and thermodynamic data to dissect the folding mechanism of the light-sensing Drosophila cryptochrome (dCRY), a 542-residue protein that binds FAD, one of the most common, complex cofactors. We show that FAD binds to multiple dCRY folding intermediates, some of which contain large amounts of unfolded polypeptide. Yet, binding occurs with association kinetics above the diffusion-limit and at sub-nanomolar affinity. Surprisingly, the first parts of dCRY to fold are independent of FAD, but later steps are FAD-driven as the remaining protein folds around the cofactor. Thus, dCRY coordinates cofactor-dependent and independent folding mechanisms to attain its native state. Furthermore, we find that not all the FAD chemical moieties are strictly required for folding: whereas the isoalloxazine ring linked to ribitol and one phosphate group (i.e., FMN) are sufficient to drive complete dCRY folding, the adenosine ring plus the phosphate groups (i.e., AMP and ADP) only allow partially folded structures. Lastly, by combining the results from optical tweezers experiments with structural data, we propose a model for the dCRY folding pathway wherein regions known to undergo conformational transitions during signal transduction are the last to fold. Altogether, our single-molecule experiments and data analysis illustrate the power and broad applicability of optical tweezers to dissect complex mechanisms that couple the folding of large proteins to cofactor binding.